Bit · Endo

Multiple Endocrine Neoplasia - MEN 1, 2A, 2B

Three autosomal dominant syndromes that produce tumors in multiple endocrine glands. Each has a signature combination and a signature gene.

Mechanism#

The MEN syndromes are autosomal dominant; each caused by a different gene with a stereotypical tumor portfolio:

Critical clinical point: in any patient with MEN 2A or 2B, prophylactic total thyroidectomy is recommended in early childhood (timing depends on specific RET codon) because medullary thyroid carcinoma is almost universal.

Differentiator Table#

MEN 1MEN 2AMEN 2B
GeneMEN1 (tumor suppressor)RET (oncogene)RET (oncogene)
PituitaryYESNoNo
ParathyroidYES (hyperparathyroidism)YESNo
Pancreatic isletYES (gastrinoma, insulinoma)NoNo
Medullary thyroid carcinomaNoYESYES
PheochromocytomaNoYESYES
Mucosal/intestinal neuromas + marfanoidNoNoYES
Mnemonic3 Ps2 Ps + medullary1 P + medullary + Mucosal neuromas + Marfan

The Pivot#

Pattern match the tumor portfolio:

  1. Hyperparathyroidism + pituitary adenoma + gastrinoma/insulinoma? → MEN 1.
  2. Medullary thyroid CA + pheo + parathyroid hyperplasia? → MEN 2A.
  3. Medullary thyroid CA + pheo + mucosal neuromas + tall thin habitus? → MEN 2B.

Whenever you see a young patient with pheo, screen for MEN 2A/2B (RET) and von Hippel-Lindau and NF1.

NBME-Style Stem#

A 24-year-old man presents with episodic headaches, palpitations, and sweating. Examination reveals a tall, lanky build with long fingers, thickened lips with visible nodules on his tongue and lips, and a thyroid mass. 24-hour urinary metanephrines are elevated. Calcitonin is markedly elevated. Which of the following is the most likely diagnosis?
Concept Anchor
Three MEN syndromes, three predictable tumor combinations: MEN1 (3 Ps), MEN2A (medullary + pheo + parathyroid), MEN2B (medullary + pheo + neuromas + marfanoid). RET mutations drive 2A/2B; MEN1 mutation drives MEN1.

← Bit Library  ·  Log a missed question →